Stress/Rest myocardial perfusion abnormalities by gated SPECT: Still the best predictor of cardiac events in stable ischemic heart disease

Journal of Nuclear Medicine

Volumn 50, Issue 4, 2009, Pages 546-553

  Gimelli, Alessia ^a,d   Rossi, Giuseppe ^b   Landi, Patrizia ^a   Marzullo, Paolo ^a   Iervasi, Giorgio ^a   L'Abbate, Antonio ^a,c   Rovai, Daniele ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b G Monasterio Foundation   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Gated spect; Ischemic heart disease; Laboratory tests; Myocardial perfusion imaging; Prognosis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC ACID DERIVATIVE; TETROFOSMIN TC 99M; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE TEST; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GATED IMAGING; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; REST; SCINTILLATION CAMERA; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; INCIDENCE; ITALY; MALE; MYOCARDIAL ISCHEMIA; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 63849120042     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.055954     Document Type: Article

References (36)

1. Gibson RS, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predis-charge exercise thallium-201 scintigraphy and coronary angiography. Circulation. 1983;68:321-336.
2. Brown KA, Boucher CA, Okada RD, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol. 1983;1:994-1001.
3. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7:464-471.
4. Pollock SG, Abbott RD, Boucher CA, Beller GA, Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease: validation of models based on these tests. Circulation. 1992;85:237-248.
5. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol. 1993;22:665-670.
6. Fintel DJ, Links JM, Brinker JA, Frank TL, Parker M, Becker LC. Improved diagnostic performance ofexercise thallium-201 single photonemissioncomputed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis. J Am Coll Cardiol. 1989;13:600-612.
7. Kiat H, Berman DS, Maddahi J. Comparison of planar and tomographic exercise thallium-201 imaging methods for the evaluation of coronary artery disease. J Am Coll Cardiol. 1989;13:613-616.
8. Berman DS, Hachamovitch R, KiatH, et al. Incremental value ofprognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. JAm Coll Cardiol. 1995;26:639-647.
9. Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability: correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol. 1994;23:1107-1114.
10. Berman DS, Kang X, Van Train KF, et al. Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 1998;32:1987-1995.
11. Nicolosi GL, Latini R, Marino P, et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Eur Heart J. 1996;17:1646-1656.
12. Pingitore A, Picano E, Varga A, et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyr-idamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. JAm Coll Cardiol. 1999;34:1769-1777.
13. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85-97.
14. Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107:708-713.
15. Barter P, Gotto AM, La Rosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol and cardiovascular events. N Engl J Med. 2007;357:1301-1310.
16. Tataru MC, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J. 2000;21:1000-1008.
17. Weber M, Dill T, Arnold R, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J. 2004;148:612-620.
18. Marzilli M, Affinito S, Focardi M. Changing scenario in chronic ischemic heart disease: therapeutic implications. Am J Cardiol. 2006;98:3J-7J.
19. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
20. Chobanian AV, Bakris GL, Black HR, et al, for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary on the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment on High Blood Cholesterol in Adults (adult treatment panel III).JAMA. 2001;285:2486-2497.
22. National Institutes of Health. Evidence-BasedGuidelines: ClinicalGuidelinesonthe Identification, Evaluation and Treatment of Overweight and Obesity in Adults: Executive Summary. Bethesda, MD: National Heart, Lung and Blood Institute; 2002.
23. Sharir T, Berman DS, Waecter PB, et al. Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality. J Nucl Med. 2001;42:1630-1638.
24. Berman DS, Abidov A, Kang X, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol. 2004;11:414-423.
25. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation. 2002;105:539-542.
26. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337-344.
27. Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol. 1996;28:34-44.
28. Elhendy A, Schinkel AF, van Domburg RT, et al. Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms. Am J Cardiol. 2006;98:585-590.
29. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007;49:227-237.
30. Pryor DB, Harrell FE Jr, Lee KL, et al. Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol. 1984;53:18-22.
31. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery-survival data. Circulation. 1983;68:939-950.
32. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol. 2005;112: e154-e235.
33. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices). Circulation. 2008;117:e350-e408.
34. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999;100:1035-1042.
35. Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42:831-837.
36. Asvold BO, Bj0ro T, Nilsen TI, Gunnell D, Vatten LJ. Thyrotropin levels and risk offatal coronary heart disease: the HUNT study. Arch Intern Med. 2008;168: 855-860.